US President Donald Trump has said he will impose reciprocal tariffs on its trading partners, including India.

Zydus Lifesciences: The company and its subsidiaries received final approval from the United States Food and Drug Administration (US FDA) to manufacture Ibuprofen and Famotidine tablets, 800 mg/26.6 ...

The Indian stock market has seen a dramatic downturn in 2025, with major indices losing substantial value. Investors are ...

Business Secretary Jonathan Reynolds will restart trade talks between India and the UK on Monday during a visit to New Delhi.

Global think tank GTRI has proposed a ‘zero-for-zero’ tariff strategy to India which is expected to counter planned ...

Marko Papic, Chief Strategist at BCA Research, believes India has the potential to outperform the US if fiscal policy in the ...

The India-US ties will depend on India's readiness to be a willing partner in the American designs on China and what it will ...

The BSE Sensex fell 418.12 points or 0.56 per cent to 74,892.94. Nifty stood at 22,656.25, down 139.65 points  or 0.68 per ...

On February 13th Donald Trump announced he had decided, for what he later called “purposes of fairness”, to employ reciprocal ...

Reciprocal U.S. trade tariffs proposed by President Donald Trump are unlikely to have a significant negative bearing on the ...

Trump, who has repeatedly criticized India’s high tariffs, especially on motorcycles, has threatened to impose reciprocal tariffs on Indian exports if the country does not make changes.